NovaBay Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $-521 | $521 | $0 | $2,309 |
Gross Profit | -42 | 42 | -38 | 1,502 |
EBITDA | -913 | -1,331 | -1,926 | -3,275 |
EBIT | -958 | -1,333 | -1,964 | -3,330 |
Net Income | -26,596 | -1,293 | -1,922 | 7,670 |
Net Change In Cash | -521 | 521 | 0 | 2,309 |
Free Cash Flow | -2,275 | -1,800 | -2,991 | -1,324 |
Cash | 7,958 | 2,309 | 5,344 | 8,467 |
Basic Shares | 5,820 | 29,380 | 29,090 | 27,075 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $9,781 | $10,455 | $14,404 |
Gross Profit | -140 | 6,481 | 6,084 | 7,781 |
EBITDA | -7,445 | -5,925 | -4,095 | -7,197 |
EBIT | -7,585 | -6,306 | -4,451 | -7,680 |
Net Income | -22,141 | -7,223 | -9,640 | -10,608 |
Net Change In Cash | 0 | 9,781 | 10,455 | 14,404 |
Free Cash Flow | -8,430 | -5,189 | -4,280 | -6,766 |
Cash | 7,958 | 430 | 3,130 | 5,362 |
Basic Shares | 5,820 | 16,980 | 600 | 230 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.23 |
2025-06-30 | -$0.34 |
2025-03-31 | -$0.40 |
2024-12-31 | -$1.99 |
